Richard Tozer

4.8k total citations · 1 hit paper
52 papers, 3.0k citations indexed

About

Richard Tozer is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Richard Tozer has authored 52 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 14 papers in Molecular Biology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Richard Tozer's work include Palliative Care and End-of-Life Issues (6 papers), Bone health and treatments (6 papers) and ATP Synthase and ATPases Research (6 papers). Richard Tozer is often cited by papers focused on Palliative Care and End-of-Life Issues (6 papers), Bone health and treatments (6 papers) and ATP Synthase and ATPases Research (6 papers). Richard Tozer collaborates with scholars based in Canada, United States and Israel. Richard Tozer's co-authors include Michelle Ghert, Nigel Colterjohn, N. Pervaiz, Forough Farrokhyar, A Figueredo, Stanley D. Dunn, Monika K. Krzyzanowska, Leeat Granek, Paolo Mazzotta and Snežana Popović and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Molecular and Cellular Biology.

In The Last Decade

Richard Tozer

52 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcoma

2008 648 citations N. Pervaiz, Nigel Colterjohn et al. Cancer profile →

Peers

Countries citing papers authored by Richard Tozer

Since Specialization

Citations

This map shows the geographic impact of Richard Tozer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Tozer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Tozer more than expected).

Fields of papers citing papers by Richard Tozer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Tozer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Tozer. The network helps show where Richard Tozer may publish in the future.

Co-authorship network of co-authors of Richard Tozer

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Tozer. A scholar is included among the top collaborators of Richard Tozer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Tozer. Richard Tozer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Neurocognitive outcomes following fetal exposure to chemotherapy for gestational breast cancer: A Canadian multi-center cohort study 2021 ·The Breast ·Cynthia Maxwell, (unknown), Ellen Warner, Maru Barrera, Christine Brezden‐Masley, (unknown), (unknown), Yolanda Madarnas, Srikala S. Sridhar, Richard Tozer, Joanne Yu, Irena Nulman	2
2	Bridging the gap: incorporating exercise evidence into clinical practice in breast cancer care 2019 ·Supportive Care in Cancer ·Jenna Smith‐Turchyn, Julie Richardson, Richard Tozer, Margaret L. McNeely, Lehana Thabane	9
3	Interventions for reducing unplanned paediatric admissions: an observational study in one hospital 2018 ·BMJ Paediatrics Open ·Kerryn Husk, Vashti Berry, Richard Tozer, (unknown), (unknown), Susan Ball, Obioha C. Ukoumunne, Stuart Logan	5
4	Safe Handling of Cytotoxics: Guideline Recommendations 2015 ·Current Oncology ·Anthony Easty, N. Coakley, Ryan R. Cheng, (unknown), Pamela Savage, Richard Tozer, Rachel E. White	48
5	Oncologists’ Protocol and Coping Strategies in Dealing with Patient Loss 2013 ·Death Studies ·Leeat Granek, Paolo Mazzotta, Richard Tozer, Monika K. Krzyzanowska	32
6	Interleukin-21 Has Activity in Patients With Metastatic Melanoma: A Phase II Study 2012 ·Journal of Clinical Oncology ·Teresa M. Petrella, Richard Tozer, Karl Bélanger, Kerry J. Savage, Ralph Wong, Michael Smylie, Suzanne Kamel‐Reid, Victor A. Tron, Bingshu E. Chen, Naomi Hunder, Linda Hagerman, Wendy Walsh, Elizabeth A. Eisenhauer	95
7	Difficult Patient Loss and Physician Culture for Oncologists Grieving Patient Loss 2012 ·Journal of Palliative Medicine ·Leeat Granek, Monika K. Krzyzanowska, Richard Tozer, Paolo Mazzotta	41
8	Primary tumor and patient characteristics in breast cancer as predictors of adjuvant therapy regimen: a regression model 2010 ·Cancer Chemotherapy and Pharmacology ·Valerie Francescutti, Forough Farrokhyar, Richard Tozer, (unknown), Peter Lovrics, (unknown), Kamyar Kahnamoui	3
9	A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcoma breakdown → 2008 ·Cancer ·N. Pervaiz, Nigel Colterjohn, Forough Farrokhyar, Richard Tozer, A Figueredo, Michelle Ghert	648
10	Cysteine-Rich Protein Reverses Weight Loss in Lung Cancer Patients Receiving Chemotherapy or Radiotherapy 2007 ·Antioxidants and Redox Signaling ·Richard Tozer, Patricia Tai, (unknown), Thiérry Ducruet, (unknown), Gustavo Bounous, (unknown), Wulf Dröge	44
11	A Phase 2 study of perifosine in advanced or metastatic breast cancer 2007 ·Breast Cancer Research and Treatment ·Natasha B. Leighl, Susan Dent, Mark Clemons, Theodore A. Vandenberg, Richard Tozer, David Warr, (unknown), David W. Hedley, Gregory R. Pond, Janet Dancey, Malcolm J. Moore	60
12	Effectiveness of sperm banking in adolescents and young adults with cancer 2007 ·Cancer ·Michael S. Neal, Kim Nagel, JoAnn Duckworth, (unknown), Marc Anthony Fischer, Carol Portwine, Richard Tozer, Ronald D. Barr	66
13	The Initial Health Assessment: an intervention to identify the supportive care needs of cancer patients 2004 ·Supportive Care in Cancer ·Dauna Crooks, Timothy J. Whelan, Leonard Reyno, Andy Willan, Richard Tozer, (unknown), Jim Miller, Michelle Tew, Paul Elliott, Mark N. Levine	21
14	Phase II trial of flavopiridol, a cyclin dependent kinase inhibitor, in untreated metastatic malignant melanoma 2004 ·Investigational New Drugs ·Susan Burdette-Radoux, Richard Tozer, Reinhard Lohmann, Ian Quirt, D. Scott Ernst, Wendy Walsh, Nancy Wainman, A. Dimitrios Colevas, Elizabeth A. Eisenhauer	72
15	Helping Patients Make Informed Choices: A Randomized Trial of a Decision Aid for Adjuvant Chemotherapy in Lymph Node-Negative Breast Cancer 2003 ·JNCI Journal of the National Cancer Institute ·Timothy J. Whelan, Carol Sawka, Mark Levine, Amiram Gafni, Leonard Reyno, Andrew R. Willan, Jacob Julian, Susan Dent, Hakam Abu-Zahra, E. Chouinard, Richard Tozer, K. Pritchard, (unknown)	185
16	A Randomized Phase II Study of Two Schedules of Bryostatin-1 (NSC339555) in Patients with Advanced Malignant Melanoma – A National Cancer Institute of Canada Clinical Trials Group Study 2002 ·Investigational New Drugs ·Richard Tozer, Susan Burdette-Radoux, (unknown), M. L. Davis, Reinhard Lohmann, (unknown), Nancy Wainman, Benny Zee, Leonard W. Seymour	18
17	Expression of Ets-related Transcription Factors and Matrix Metalloproteinase Genes in Human Breast Cancer Cells 2002 ·Breast Cancer Research and Treatment ·(unknown), (unknown), Gurmit Singh, Richard Tozer	29
18	Genetically modified dendritic cells in cancer therapy: Implications for transfusion medicine 2001 ·Transfusion Medicine Reviews ·Ronan Foley, Richard Tozer, Yonghong Wan	12
19	Immunolocalization of matrix metalloproteinases and their inhibitors in clinical specimens of bone metastasis from breast carcinoma 2000 ·Clinical & Experimental Metastasis ·Šárka Lhoták, (unknown), (unknown), Wilhelmina Duivenvoorden, Richard Tozer, Gurmit Singh	19
20	Activation of Escherichia coli F1-ATPase by lauryldimethylamine oxide and ethylene glycol: relationship of ATPase activity to the interaction of the .epsilon. and .beta. subunits 1990 ·Biochemistry ·Stanley D. Dunn, Richard Tozer, (unknown)	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact